Patient Blood Management Market Research Report - Forecast till 2027

Patient Blood Management Market Research Report: By Product (Instruments, Accessories, Reagents and Kits, Software), By Component (Whole Blood, Plasma) and By End-User (Blood Banks, Hospitals, Diagnostic Clinics and & Pathology Labs)-Forecast to 2027

ID: MRFR/HC/7326-HCR | February, 2021 | Region : Global

Table of Contents

1. EXECUTIVE SUMMARY

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Primary Research

3.3. Secondary Research

3.4. Market Size Estimation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Porter’s Five Forces Analysis

5.1.1. Bargaining Power of Suppliers

5.1.2. Bargaining Power of Buyers

5.1.3. Threat of New Entrants

5.1.4. Threat of Substitutes

5.1.5. Intensity of Rivalry

5.2. Value Chain Analysis/Supply Chain Analysis

6. GLOBAL PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT

6.1. Overview

6.2. Instruments

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

6.2.1. Blood Processing Devices

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

6.2.1.1. Centrifuges

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

6.2.1.2. Blood Cell Processors

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

6.2.2. Blood Transfusion Devices

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

6.2.2.1. Apheresis Machines

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

6.2.2.2. Plasma & Plasma Component Separators

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

6.2.2.3. Cell Salvage Systems

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

6.2.2.4. Others

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

6.2.3. Blood Culture Screening Devices

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

6.2.3.1. Automated Blood Culture Systems

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

6.2.3.2. Supporting Laboratory Equipment

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

6.2.4. Diagnostic & Testing Instruments

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

6.2.4.1. PCR Instruments

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

6.2.4.2. Hematology Analyzers

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

6.2.4.3. NGS Platforms

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

6.2.4.4. Blood Grouping Analyzers

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

6.2.5. Blood Storage Devices

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

6.2.5.1. Medical Refrigerators

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

6.2.5.2. Medical Freezers

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

6.3. Accessories

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

6.3.1. Syringes & Needles

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

6.3.2. Vials & Tubes

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

6.3.3. Blood Bags

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

6.3.4. Others

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

6.4. Reagents and Kits

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

6.4.1. Culture Media

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

6.4.2. Reagents

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

6.4.3. Kits

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

6.4.4. Others

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

6.5. Software

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

7. GLOBAL PATIENT BLOOD MANAGEMENT MARKET, BY COMPONENT

7.1. Overview

7.2. Whole Blood

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

7.3. Plasma

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

8. GLOBAL PATIENT BLOOD MANAGEMENT MARKET, BY END USER

8.1. Overview

8.2. Blood Banks

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

8.3. Hospitals

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

8.4. Diagnostic Clinics and & Pathology Labs

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

9. GLOBAL PATIENT BLOOD MANAGEMENT MARKET, BY REGION

9.1. Overview

9.2. Americas

9.2.1. North America

9.2.1.1. US

9.2.1.2. Canada

9.2.2. Latin America

9.3. Europe

9.3.1. Western Europe

9.3.1.1. Germany

9.3.1.2. France

9.3.1.3. Italy

9.3.1.4. Spain

9.3.1.5. UK

9.3.1.6. Rest of Western Europe

9.3.2. Eastern Europe

9.4. Asia-Pacific

9.4.1. Japan

9.4.2. China

9.4.3. India

9.4.4. Australia

9.4.5. South Korea

9.4.6. Rest of Asia-Pacific

9.5. Middle East & Africa

9.5.1. Middle East

9.5.2. Africa

10. COMPANY LANDSCAPE

10.1.1. Overview

10.1.2. Competitive Analysis

10.1.3. Market Share Analysis

10.1.4. Major Growth Strategy in the global patient blood management market

10.1.5. Competitive Benchmarking

10.1.6. Leading Player in terms of Number of Developments in the global patient blood management market

10.1.7. Key Developments & Growth Strategies

10.1.7.1. Product Launch

10.1.7.2. Merger & Acquisition

10.1.7.3. Joint Ventures

10.1.8. Major Players Financial Matrix

10.1.8.1. Sales & Operating Income 2019

10.1.8.2. Major Players R&D Expenditure 2019


11. COMPANY PROFILES

11.1. Biomérieux SA

11.1.1. Company Overview

11.1.2. Product Type Overview

11.1.3. Financial Overview

11.1.4. Key Developments

11.1.5. SWOT Analysis

11.1.6. Key Strategies

11.2. Bio-Rad Laboratories, Inc.

11.2.1. Company Overview

11.2.2. Product Type Overview

11.2.3. Financial Overview

11.2.4. Key Developments

11.2.5. SWOT Analysis

11.2.6. Key Strategies

11.3. Fresenius Se & Co. KGaA

11.3.1. Company Overview

11.3.2. Product Type Overview

11.3.3. Financial Overview

11.3.4. Key Developments

11.3.5. SWOT Analysis

11.3.6. Key Strategies

11.4. B. Braun Melsungen AG

11.4.1. Company Overview

11.4.2. Product Type Overview

11.4.3. Financial Overview

11.4.4. Key Developments

11.4.5. SWOT Analysis

11.4.6. Key Strategies

11.5. Abbott Laboratories

11.5.1. Company Overview

11.5.2. Product Type Overview

11.5.3. Financial Overview

11.5.4. Key Developments

11.5.5. SWOT Analysis

11.5.6. Key Strategies

11.6. Danaher Corporation

11.6.1. Company Overview

11.6.2. Product Type Overview

11.6.3. Financial Overview

11.6.4. Key Developments

11.6.5. SWOT Analysis

11.6.6. Key Strategies

11.7. Hitachi, Ltd.

11.7.1. Company Overview

11.7.2. Product Type Overview

11.7.3. Financial Overview

11.7.4. Key Developments

11.7.5. SWOT Analysis

11.7.6. Key Strategies

11.8. Terumo Corporation

11.8.1. Company Overview

11.8.2. Product Type Overview

11.8.3. Financial Overview

11.8.4. Key Developments

11.8.5. SWOT Analysis

11.8.6. Key Strategies

11.9. Grifols, S.A

11.9.1. Company Overview

11.9.2. Product Type Overview

11.9.3. Financial Overview

11.9.4. Key Developments

11.9.5. SWOT Analysis

11.9.6. Key Strategies

11.10. Immucor, Inc.

11.10.1. Company Overview

11.10.2. Product Type Overview

11.10.3. Financial Overview

11.10.4. Key Developments

11.10.5. SWOT Analysis

11.10.6. Key Strategies

11.11. Others

12. APPENDIX

12.1. References

12.2. Related Reports


LIST OF TABLES

TABLE 1 GLOBAL PATIENT BLOOD MANAGEMENT MARKET SYNOPSIS, 2019–2027

TABLE 2 GLOBAL PATIENT BLOOD MANAGEMENT MARKET ESTIMATES & FORECAST, 2019–2027 (USD MILLION)

TABLE 3 GLOBAL PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2019–2027 (USD MILLION)

TABLE 4 GLOBAL PATIENT BLOOD MANAGEMENT MARKET, BY COMPONENT, 2019–2027 (USD MILLION)

TABLE 5 GLOBAL PATIENT BLOOD MANAGEMENT MARKET, BY END USER, 2019–2027 (USD MILLION)

TABLE 6 GLOBAL PATIENT BLOOD MANAGEMENT MARKET, BY REGION, 2019–2027 (USD MILLION)

TABLE 7 NORTH AMERICA: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2019–2027 (USD MILLION)

TABLE 8 NORTH AMERICA: PATIENT BLOOD MANAGEMENT MARKET, BY COMPONENT, 2019–2027 (USD MILLION)

TABLE 9 NORTH AMERICA: PATIENT BLOOD MANAGEMENT MARKET, BY END USER, 2019–2027 (USD MILLION)

TABLE 10 US: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2019–2027 (USD MILLION)

TABLE 11 US: PATIENT BLOOD MANAGEMENT MARKET, BY COMPONENT, 2019–2027 (USD MILLION)

TABLE 12 US: PATIENT BLOOD MANAGEMENT MARKET, BY END USER, 2019–2027 (USD MILLION)

TABLE 13 CANADA: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2019–2027 (USD MILLION)

TABLE 14 CANADA: PATIENT BLOOD MANAGEMENT MARKET, BY COMPONENT, 2019–2027 (USD MILLION)

TABLE 15 CANADA: PATIENT BLOOD MANAGEMENT MARKET, BY END USER, 2019–2027 (USD MILLION)

TABLE 16 LATIN AMERICA: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2019–2027 (USD MILLION)

TABLE 17 LATIN AMERICA: PATIENT BLOOD MANAGEMENT MARKET, BY COMPONENT, 2019–2027 (USD MILLION)

TABLE 18 LATIN AMERICA: PATIENT BLOOD MANAGEMENT MARKET, BY END USER, 2019–2027 (USD MILLION)

TABLE 19 EUROPE: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2019–2027 (USD MILLION)

TABLE 20 EUROPE: PATIENT BLOOD MANAGEMENT MARKET, BY COMPONENT, 2019–2027 (USD MILLION)

TABLE 21 EUROPE: PATIENT BLOOD MANAGEMENT MARKET, BY END USER, 2019–2027 (USD MILLION)

TABLE 22 WESTERN EUROPE: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2019–2027 (USD MILLION)

TABLE 23 WESTERN EUROPE: PATIENT BLOOD MANAGEMENT MARKET, BY COMPONENT, 2019–2027 (USD MILLION)

TABLE 24 WESTERN EUROPE: PATIENT BLOOD MANAGEMENT MARKET, BY END USER, 2019–2027 (USD MILLION)

TABLE 25 EASTERN EUROPE: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2019–2027 (USD MILLION)

TABLE 26 EASTERN EUROPE: PATIENT BLOOD MANAGEMENT MARKET, BY COMPONENT, 2019–2027 (USD MILLION)

TABLE 27 EASTERN EUROPE: PATIENT BLOOD MANAGEMENT MARKET, BY END USER, 2019–2027 (USD MILLION)

TABLE 28 ASIA-PACIFIC: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2019–2027 (USD MILLION)

TABLE 29 ASIA-PACIFIC: PATIENT BLOOD MANAGEMENT MARKET, BY COMPONENT, 2019–2027 (USD MILLION)

TABLE 30 ASIA-PACIFIC: PATIENT BLOOD MANAGEMENT MARKET, BY END USER, 2019–2027 (USD MILLION)

TABLE 31 MIDDLE EAST & AFRICA: PATIENT BLOOD MANAGEMENT MARKET, BY PRODUCT, 2019–2027 (USD MILLION)

TABLE 32 MIDDLE EAST & AFRICA: PATIENT BLOOD MANAGEMENT MARKET, BY COMPONENT, 2019–2027 (USD MILLION)

TABLE 33 MIDDLE EAST & AFRICA: PATIENT BLOOD MANAGEMENT MARKET, BY END USER, 2019–2027 (USD MILLION)  

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL PATIENT BLOOD MANAGEMENT MARKET

FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL PATIENT BLOOD MANAGEMENT MARKET

FIGURE 4 GLOBAL PATIENT BLOOD MANAGEMENT MARKET SHARE, BY PRODUCT, 2019 (%)

FIGURE 5 GLOBAL PATIENT BLOOD MANAGEMENT MARKET SHARE, BY COMPONENT, 2019 (%)

FIGURE 6 GLOBAL PATIENT BLOOD MANAGEMENT MARKET SHARE, BY END USER, 2019 (%)

FIGURE 7 GLOBAL PATIENT BLOOD MANAGEMENT MARKET SHARE, BY REGION, 2019 (%)

FIGURE 7 AMERICAS: PATIENT BLOOD MANAGEMENT MARKET SHARE BY REGION, 2019 (%)

FIGURE 8 NORTH AMERICA: PATIENT BLOOD MANAGEMENT MARKET SHARE, BY COUNTRY, 2019 (%)

FIGURE 9 EUROPE: PATIENT BLOOD MANAGEMENT MARKET SHARE, BY REGION, 2019 (%)

FIGURE 10 WESTERN EUROPE: PATIENT BLOOD MANAGEMENT MARKET SHARE, BY COUNTRY, 2019 (%)

FIGURE 11 ASIA-PACIFIC: PATIENT BLOOD MANAGEMENT MARKET SHARE, BY COUNTRY, 2019 (%)

FIGURE 12 MIDDLE EAST & AFRICA: PATIENT BLOOD MANAGEMENT MARKET SHARE, BY COUNTRY, 2019 (%)

FIGURE 13 GLOBAL PATIENT BLOOD MANAGEMENT MARKET: COMPANY SHARE ANALYSIS, 2019 (%)

FIGURE 14 BIOMÉRIEUX SA: KEY FINANCIALS

FIGURE 15 BIOMÉRIEUX SA: SEGMENTAL REVENUE

FIGURE 16 BIOMÉRIEUX SA: REGIONAL REVENUE

FIGURE 17 BIO-RAD LABORATORIES, INC.: KEY FINANCIALS

FIGURE 18 BIO-RAD LABORATORIES, INC.: SEGMENTAL REVENUE

FIGURE 19 BIO-RAD LABORATORIES, INC.: REGIONAL REVENUE

FIGURE 20 FRESENIUS SE & CO. KGAA: KEY FINANCIALS

FIGURE 21 FRESENIUS SE & CO. KGAA: SEGMENTAL REVENUE

FIGURE 22 FRESENIUS SE & CO. KGAA: REGIONAL REVENUE

FIGURE 23 B. BRAUN MELSUNGEN AG: KEY FINANCIALS

FIGURE 24 B. BRAUN MELSUNGEN AG: SEGMENTAL REVENUE

FIGURE 25 B. BRAUN MELSUNGEN AG: REGIONAL REVENUE

FIGURE 26 ABBOTT LABORATORIES: KEY FINANCIALS

FIGURE 27 ABBOTT LABORATORIES: SEGMENTAL REVENUE

FIGURE 28 ABBOTT LABORATORIESREGIONAL REVENUE

FIGURE 29 DANAHER CORPORATION: KEY FINANCIALS

FIGURE 30 DANAHER CORPORATION: SEGMENTAL REVENUE

FIGURE 31 DANAHER CORPORATION: REGIONAL REVENUE

FIGURE 32 HITACHI, LTD: KEY FINANCIALS

FIGURE 33 HITACHI, LTD.: SEGMENTAL REVENUE

FIGURE 34 HITACHI, LTD: REGIONAL REVENUE

FIGURE 35 TERUMO CORPORATION.: KEY FINANCIALS

FIGURE 36 TERUMO CORPORATION.: SEGMENTAL REVENUE

FIGURE 37 TERUMO CORPORATION.: REGIONAL REVENUE

FIGURE 38 GRIFOLS, S.A: KEY FINANCIALS

FIGURE 39 GRIFOLS, S.A: SEGMENTAL REVENUE

FIGURE 40 GRIFOLS, S.A: REGIONAL REVENUE

FIGURE 41 IMMUCOR, INC.: KEY FINANCIALS

FIGURE 42 IMMUCOR, INC.: SEGMENTAL REVENUE

FIGURE 43 IMMUCOR, INC.: REGIONAL REVENUE



This table of content is tentative and subject to change as the research progresses.

Please Note:  Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.

Patient Blood Management Market